drugset

drugset / Trial / NCT02434523

Trial of the Treatment of Chronic Laryngitis With Amitryptiline

NCT02434523 ↗

Phase 2/3 Terminated 30 enrolled Boston Medical Center American Laryngological Association · collab

RandomizedParallel-groupTriple-blindTreatment

Summary

The study will compare the effectiveness of amitriptyline versus placebo (inactive medication) in treating chronic laryngitis.

Timeline

Start: 2013-09
Primary completion: 2015-01
Completion: 2015-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Amitriptyline	Small molecule	50 mg	—

Indications